Clarity in cell line development

Solentim appoints new sales manager for USA East

Solentim is pleased to announce the appointment of Jake Isaacs to the role of Sales Manager, USA East Coast. Jake is based in the Greater Boston area and holds a PhD in biochemistry/biophysics with postdoctoral training in immunology, cell biology and molecular diagnostics. He has a passion for cutting-edge technology and its application to outstanding …

Read more Solentim appoints new sales manager for USA East

Rapid on-boarding of the VIPS platform helped provide a competitive edge for Biotech start-up and a successful IND outcome

As the pressures on cell line development (CLD) laboratories are ever-increasing to expand into the expression of new modalities, you need a cell line development workflow that seamlessly works from day one. Biotheus, a new innovator biotech company, wanted a to invest in instrumentation to support CLD activities that could provide the following key attributes: …

Read more Rapid on-boarding of the VIPS platform helped provide a competitive edge for Biotech start-up and a successful IND outcome

Solentim and ATUM to bundle Leap-In Transposase® with the VIPS™ single cell cloning instrument for cell line development

Bournemouth, UK and Newark, CA, USA, 20th April 2020 / Solentim, a global leader in cell line development (CLD) instrumentation, and bioengineering company ATUM, today announced that Solentim will bundle access to the Leap-In Transposase® platform together with the Solentim VIPS™ single cell cloning instrument. Leap-In Transposases enable stable high titer clones to be isolated whilst screening …

Read more Solentim and ATUM to bundle Leap-In Transposase® with the VIPS™ single cell cloning instrument for cell line development

Podcast | Novel Methodologies for Rapid Vaccine Production

In this Podcast, Mark Stockdale and Duncan Borthwick discuss COVID-19 and developments in vaccine production methodologies with reference to a paper from GSK , “Integration of high-throughput analytics and cell imaging enables direct early productivity and product quality assessment during Chinese Hamster ovary cell line development for a complex multi-subunit vaccine antigen" which features the …

Read more Podcast | Novel Methodologies for Rapid Vaccine Production

GSK pioneer a single-step cloning strategy to generate novel recombinant sub unit vaccine candidates.

Currently we are living in unprecedented times with a global health threat from a novel respiratory disease that has spread within weeks.  We are trying to subvert a large percentage of the population succumbing to this virus through early detection and isolation strategy.  There is the potential need for a long-term treatment if variants of …

Read more GSK pioneer a single-step cloning strategy to generate novel recombinant sub unit vaccine candidates.

Podcast | Viral Production for Gene Therapy

In the latest edition of this Podcast series, Duncan Borthwick speaks to Mark Stockdale about the developing regulatory landscape around viral production for clinical gene therapy. Topics include transient and stable expression, HEK293 cells and the choice of the appropriate cells, moving from research to clinical environments and an optimistic quote from Nobel laureate Michael …

Read more Podcast | Viral Production for Gene Therapy

Translate »